Benzofuran TRPM3 Antagonists for Potency and Side-Effect Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a significant medical need for novel, alternative, and/or better therapeutics for TRPM3 mediated disorders such as pain and epilepsy, particularly inflammatory pain and epileptic encephalopathies, with a focus on compounds that have good potency, low side-effects, and favorable pharmacokinetic or -dynamic properties.
Innovation Solution
Development of benzofuran derivatives that act as TRPM3 antagonists, which can be used as modulators for TRPM3 mediated disorders, including the prevention or treatment of pain, epilepsy, and inflammatory hypersensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing TRPM3 antagonists are used, then some therapeutic effect is achieved, but they lack optimal potency, have side effects, or show poor pharmacokinetic properties
Solution Approach 1:
The patent applies parameter changes by systematically modifying chemical structure parameters of TRPM3 antagonists. The core benzofuran structure is optimized through varying substituents at different positions (R1-R8 groups), adjusting molecular properties to improve potency while reducing side effects. This includes changing lipophilicity, molecular weight, and functional group characteristics to achieve better therapeutic profiles.
Solution Approach 2:
The patent employs composite material principles by creating complex multi-substituent benzofuran derivatives that combine multiple functional groups within a single molecule. These composite structures integrate hydrophobic and hydrophilic regions, electron-donating and electron-withdrawing groups, to optimize both efficacy and safety profiles simultaneously.
2Reliability
If existing TRPM3 antagonists are used, then some pain relief is achieved, but pharmacokinetic properties are not optimal
Solution Approach 1:
The patent optimizes pharmacokinetic parameters by adjusting molecular characteristics of the benzofuran derivatives. This includes modifying metabolic stability through strategic placement of substituents that resist enzymatic degradation, adjusting solubility through polar group selection, and optimizing molecular size and shape for better tissue penetration and distribution.
3Reliability
If novel TRPM3 antagonists are developed, then therapeutic potential is improved, but development complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the complex benzofuran molecule into distinct functional modules (R1-R8 substituent positions). Each position can be independently optimized for specific properties, allowing systematic exploration of structure-activity relationships without overwhelming complexity. This modular approach simplifies the development process by enabling focused optimization of individual regions.
Data Source
AI summary
The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain, epilepsy and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.